ID   PDE4D_RAT               Reviewed;         803 AA.
AC   P14270; A1E347; A1EC59; F1M1H7; O35470; Q6TRI0; Q8CG04; Q8CG06;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 4.
DT   02-OCT-2024, entry version 190.
DE   RecName: Full=3',5'-cyclic-AMP phosphodiesterase 4D {ECO:0000305};
DE            EC=3.1.4.53;
DE   AltName: Full=DPDE3;
DE   AltName: Full=cAMP-specific phosphodiesterase 4D {ECO:0000305};
GN   Name=Pde4d;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 31), AND INDUCTION.
RC   TISSUE=Testis;
RX   PubMed=2554303; DOI=10.1073/pnas.86.21.8197;
RA   Swinnen J.V., Joseph D.R., Conti M.;
RT   "The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by
RT   hormones and cAMP.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:8197-8201(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 31; 32 AND 33).
RX   PubMed=8034568; DOI=10.1016/s0021-9258(17)32297-4;
RA   Sette C., Vicini E., Conti M.;
RT   "The ratPDE3/IVd phosphodiesterase gene codes for multiple proteins
RT   differentially activated by cAMP-dependent protein kinase.";
RL   J. Biol. Chem. 269:18271-18274(1994).
RN   [3]
RP   SEQUENCE REVISION TO 6.
RA   Conti M.;
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 31 AND 32).
RC   STRAIN=Wistar;
RX   PubMed=8276818; DOI=10.1016/s0021-9258(17)42355-6;
RA   Monaco L., Vicini E., Conti M.;
RT   "Structure of two rat genes coding for closely related rolipram-sensitive
RT   cAMP phosphodiesterases. Multiple mRNA variants originate from alternative
RT   splicing and multiple start sites.";
RL   J. Biol. Chem. 269:347-357(1994).
RN   [5]
RP   ERRATUM OF PUBMED:8276818.
RA   Monaco L., Vicini E., Conti M.;
RL   J. Biol. Chem. 269:20806-20806(1994).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RA   Jin S.-L.C., Kuo W.-P., Conti M.;
RT   "Characterization of a cAMP-specific phosphodiesterase variant (PDE4D4)
RT   expressed in the rat brain.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 6 AND 7).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=12834813; DOI=10.1016/s0898-6568(03)00042-1;
RA   Wang D., Deng C., Bugaj-Gaweda B., Kwan M., Gunwaldsen C., Leonard C.,
RA   Xin X., Hu Y., Unterbeck A., De Vivo M.;
RT   "Cloning and characterization of novel PDE4D isoforms PDE4D6 and PDE4D7.";
RL   Cell. Signal. 15:883-891(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 5 AND 8), BIOPHYSICOCHEMICAL
RP   PROPERTIES, ACTIVITY REGULATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=17261351; DOI=10.1016/j.bbagen.2006.12.006;
RA   Levallet G., Levallet J., Bonnamy P.J.;
RT   "Alterations in proteoglycan synthesis selectively impair FSH-induced
RT   particulate cAMP-phosphodiesterase 4 (PDE4) activation in immature rat
RT   Sertoli cells.";
RL   Biochim. Biophys. Acta 1770:638-648(2007).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 9).
RA   Gaweda B., De Vivo M., Wang D.;
RT   "Novel PDE4D isoform, PDE4D9.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE OF 224-672.
RC   TISSUE=Testis;
RX   PubMed=2546153; DOI=10.1073/pnas.86.14.5325;
RA   Swinnen J.V., Joseph D.R., Conti M.;
RT   "Molecular cloning of rat homologues of the Drosophila melanogaster dunce
RT   cAMP phosphodiesterase: evidence for a family of genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:5325-5329(1989).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 226-803 (ISOFORM 33), AND NUCLEOTIDE SEQUENCE
RP   [MRNA] OF 253-803 (ISOFORM 31).
RX   PubMed=7958996; DOI=10.1016/0378-1119(94)90155-4;
RA   Bolger G.B., Rodgers L., Riggs M.;
RT   "Differential CNS expression of alternative mRNA isoforms of the mammalian
RT   genes encoding cAMP-specific phosphodiesterases.";
RL   Gene 149:237-244(1994).
RN   [13]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=10187850; DOI=10.1074/jbc.274.15.10557;
RA   Liu H., Maurice D.H.;
RT   "Phosphorylation-mediated activation and translocation of the cyclic AMP-
RT   specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase
RT   and mitogen-activated protein kinases. A potential mechanism allowing for
RT   the coordinated regulation of PDE4D activity and targeting.";
RL   J. Biol. Chem. 274:10557-10565(1999).
RN   [14]
RP   INTERACTION WITH PDE4DIP.
RX   PubMed=11134006; DOI=10.1074/jbc.m006546200;
RA   Verde I., Pahlke G., Salanova M., Zhang G., Wang S., Coletti D.,
RA   Onuffer J., Jin S.-L.C., Conti M.;
RT   "Myomegalin is a novel protein of the Golgi/centrosome that interacts with
RT   a cyclic nucleotide phosphodiesterase.";
RL   J. Biol. Chem. 276:11189-11198(2001).
RN   [15]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH THE CENTROSOME (ISOFORM 33).
RX   PubMed=11285255; DOI=10.1074/jbc.c000911200;
RA   Tasken K.A., Collas P., Kemmner W.A., Witczak O., Conti M., Tasken K.;
RT   "Phosphodiesterase 4D and protein kinase a type II constitute a signaling
RT   unit in the centrosomal area.";
RL   J. Biol. Chem. 276:21999-22002(2001).
RN   [16]
RP   ALTERNATIVE SPLICING (ISOFORMS 4; 5; 6; 7; 8; 9; 31; 32 AND 33).
RX   PubMed=15717866; DOI=10.1042/bj20050030;
RA   Richter W., Jin S.L., Conti M.;
RT   "Splice variants of the cyclic nucleotide phosphodiesterase PDE4D are
RT   differentially expressed and regulated in rat tissue.";
RL   Biochem. J. 388:803-811(2005).
RN   [17]
RP   INTERACTION WITH SHANK2, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17244609; DOI=10.1074/jbc.m610857200;
RA   Lee J.H., Richter W., Namkung W., Kim K.H., Kim E., Conti M., Lee M.G.;
RT   "Dynamic regulation of cystic fibrosis transmembrane conductance regulator
RT   by competitive interactions of molecular adaptors.";
RL   J. Biol. Chem. 282:10414-10422(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-137, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-52 AND SER-56 (ISOFORM 5), AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Hydrolyzes the second messenger cAMP, which is a key
CC       regulator of many important physiological processes.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic AMP + H2O = AMP + H(+); Xref=Rhea:RHEA:25277,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58165,
CC         ChEBI:CHEBI:456215; EC=3.1.4.53;
CC         Evidence={ECO:0000250|UniProtKB:Q08499};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25278;
CC         Evidence={ECO:0000250|UniProtKB:Q08499};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q08499};
CC       Note=Binds 2 divalent metal cations per subunit. Site 1 may
CC       preferentially bind zinc ions. {ECO:0000250|UniProtKB:Q08499};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q08499};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q07343};
CC       Note=Binds 2 divalent metal cations per subunit. Site 2 has a
CC       preference for magnesium and/or manganese ions.
CC       {ECO:0000250|UniProtKB:Q08499};
CC   -!- ACTIVITY REGULATION: Activated by phosphatidic acid (By similarity).
CC       Inhibited by rolipram. {ECO:0000250, ECO:0000269|PubMed:17261351}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=18 pmol/min/mg enzyme for cAMP (in the absence of follicle-
CC         stimulating hormone (FSH)) {ECO:0000269|PubMed:17261351};
CC         Vmax=5 pmol/min/mg enzyme for cAMP (in the presence of follicle-
CC         stimulating hormone (FSH)) {ECO:0000269|PubMed:17261351};
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic AMP degradation; AMP from
CC       3',5'-cyclic AMP: step 1/1.
CC   -!- SUBUNIT: Homodimer for the long isoforms. Isoforms with truncated N-
CC       termini are monomeric. Binds ARRB2. Isoform 33 is part of a ternary
CC       complex containing PRKAR2A, PRKAR2B and AKAP9. Identified in a complex
CC       composed of RYR1, PDE4D, PKA, FKBP1A and protein phosphatase 1 (PP1)
CC       (By similarity). Interacts with PDE4DIP. Isoform 5 interacts (via N-
CC       terminal region) with SHANK2 (via proline-rich region); the interaction
CC       is increased in a PKA-dependent manner. Isoform 33, isoform 4, isoform
CC       7, isoform 8 and isoform 9 but not isoform 32 and isoform 6 interact
CC       with SHANK2. Isoform 31 interacts weakly with SHANK2. {ECO:0000250,
CC       ECO:0000269|PubMed:11134006, ECO:0000269|PubMed:17244609}.
CC   -!- INTERACTION:
CC       P14270; P08588: ADRB1; Xeno; NbExp=2; IntAct=EBI-8333209, EBI-991009;
CC       P14270-8; Q9QX74: Shank2; NbExp=4; IntAct=EBI-9032440, EBI-397902;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane. Cytoplasm. Membrane.
CC       Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, microtubule
CC       organizing center, centrosome. Note=Found in the soluble fraction,
CC       associated with membranes, and associated with the cytoskeleton and the
CC       centrosome. Colocalized with SHANK2 to the apical membrane of colonic
CC       crypt cells.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=9;
CC       Name=4; Synonyms=PDE4D4;
CC         IsoId=P14270-5; Sequence=Displayed;
CC       Name=33; Synonyms=PDE4D3, PDE3.3;
CC         IsoId=P14270-1; Sequence=VSP_012398, VSP_012399;
CC       Name=31; Synonyms=PDE3.1;
CC         IsoId=P14270-2; Sequence=VSP_004581;
CC       Name=32; Synonyms=PDE3.2;
CC         IsoId=P14270-3; Sequence=VSP_004582;
CC       Name=5; Synonyms=PDE4D5;
CC         IsoId=P14270-8; Sequence=VSP_053485;
CC       Name=6; Synonyms=PDE4D6;
CC         IsoId=P14270-7; Sequence=VSP_012404, VSP_012405;
CC       Name=7; Synonyms=PDE4D7;
CC         IsoId=P14270-4; Sequence=VSP_012400, VSP_012401;
CC       Name=8; Synonyms=PDE4D8;
CC         IsoId=P14270-9; Sequence=VSP_053486;
CC       Name=9; Synonyms=PDE4D9;
CC         IsoId=P14270-6; Sequence=VSP_012402, VSP_012403;
CC   -!- TISSUE SPECIFICITY: Expressed in epithelial cells. Isoform 33, isoform
CC       4, isoform 5 and isoform 9 are expressed in brain. Isoform 33, isoform
CC       5, isoform 8 and isoform 9 are expressed in heart (at protein level).
CC       Isoform 4 and isoform 6 are strongly expressed in cortex and
CC       cerebellum. Isoform 7 is strongly expressed in cortex and testis;
CC       weakly expressed in kidney, lung, spleen and cerebellum. Isoform 8 is
CC       strongly expressed in lung, heart and liver. Isoform 31, isoform 32,
CC       isoform 33, isoform 5 and isoform 9 are widely distributed.
CC       {ECO:0000269|PubMed:17244609, ECO:0000269|PubMed:17261351}.
CC   -!- INDUCTION: Up-regulated by cAMP and follicle-stimulating hormone.
CC       {ECO:0000269|PubMed:2554303}.
CC   -!- PTM: Isoform 1 and isoform 9 are rapidly activated by PKA through
CC       phosphorylation. Long isoforms that share a conserved PKA
CC       phosphorylation site in the N-terminus are also activated.
CC       {ECO:0000269|PubMed:10187850}.
CC   -!- PTM: Sumoylation of long isoforms by PIAS4 augments their activation by
CC       PKA phosphorylation and represses their inhibition by ERK
CC       phosphorylation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cyclic nucleotide phosphodiesterase family.
CC       PDE4 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U09455; AAA20401.1; -; mRNA.
DR   EMBL; U09457; AAB81869.1; -; mRNA.
DR   EMBL; U09456; AAA20393.1; -; mRNA.
DR   EMBL; U01280; AAA18925.1; -; Unassigned_DNA.
DR   EMBL; U01278; AAA18925.1; JOINED; Unassigned_DNA.
DR   EMBL; U01282; AAA18925.1; JOINED; Unassigned_DNA.
DR   EMBL; U01283; AAA18925.1; JOINED; Unassigned_DNA.
DR   EMBL; U01284; AAA18925.1; JOINED; Unassigned_DNA.
DR   EMBL; U01285; AAA18925.1; JOINED; Unassigned_DNA.
DR   EMBL; U01286; AAA18925.1; JOINED; Unassigned_DNA.
DR   EMBL; U01287; AAA18925.1; JOINED; Unassigned_DNA.
DR   EMBL; U01279; AAA18925.1; JOINED; Unassigned_DNA.
DR   EMBL; U01280; AAA18924.1; -; Unassigned_DNA.
DR   EMBL; U01278; AAA18924.1; JOINED; Unassigned_DNA.
DR   EMBL; U01282; AAA18924.1; JOINED; Unassigned_DNA.
DR   EMBL; U01283; AAA18924.1; JOINED; Unassigned_DNA.
DR   EMBL; U01284; AAA18924.1; JOINED; Unassigned_DNA.
DR   EMBL; U01285; AAA18924.1; JOINED; Unassigned_DNA.
DR   EMBL; U01286; AAA18924.1; JOINED; Unassigned_DNA.
DR   EMBL; U01287; AAA18924.1; JOINED; Unassigned_DNA.
DR   EMBL; U01279; AAA18924.1; JOINED; Unassigned_DNA.
DR   EMBL; AF031373; AAB95266.1; -; mRNA.
DR   EMBL; AF536974; AAN10116.1; -; mRNA.
DR   EMBL; EF102484; ABK97408.1; -; mRNA.
DR   EMBL; EF121818; ABL14108.1; -; mRNA.
DR   EMBL; AF536979; AAN10121.1; -; mRNA.
DR   EMBL; AY388961; AAQ90405.1; -; mRNA.
DR   EMBL; AABR06012736; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012737; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012738; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012739; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012740; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012741; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012742; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012743; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012745; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012746; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012747; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012748; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012749; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012750; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012751; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012752; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012753; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012754; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012755; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012756; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012757; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012758; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012759; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR06012760; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L27059; AAA56857.1; -; mRNA.
DR   EMBL; L27060; AAC26969.1; -; mRNA.
DR   PIR; B53109; B53109.
DR   PIR; I61259; I61259.
DR   RefSeq; NP_001106799.1; NM_001113328.1.
DR   RefSeq; NP_001106800.1; NM_001113329.1. [P14270-4]
DR   RefSeq; NP_001106803.1; NM_001113332.1. [P14270-8]
DR   RefSeq; NP_001106805.1; NM_001113334.1. [P14270-9]
DR   RefSeq; NP_058728.1; NM_017032.1. [P14270-1]
DR   RefSeq; XP_008758944.1; XM_008760722.2. [P14270-7]
DR   RefSeq; XP_008758945.1; XM_008760723.1. [P14270-3]
DR   AlphaFoldDB; P14270; -.
DR   SMR; P14270; -.
DR   BioGRID; 246765; 5.
DR   IntAct; P14270; 3.
DR   MINT; P14270; -.
DR   STRING; 10116.ENSRNOP00000015138; -.
DR   BindingDB; P14270; -.
DR   ChEMBL; CHEMBL2712; -.
DR   DrugCentral; P14270; -.
DR   iPTMnet; P14270; -.
DR   PhosphoSitePlus; P14270; -.
DR   PaxDb; 10116-ENSRNOP00000067171; -.
DR   Ensembl; ENSRNOT00000066384.5; ENSRNOP00000063446.2; ENSRNOG00000042536.5. [P14270-9]
DR   Ensembl; ENSRNOT00000067546.4; ENSRNOP00000062384.2; ENSRNOG00000042536.5. [P14270-7]
DR   Ensembl; ENSRNOT00000110594.1; ENSRNOP00000076534.1; ENSRNOG00000042536.5. [P14270-4]
DR   Ensembl; ENSRNOT00000111781.1; ENSRNOP00000094176.1; ENSRNOG00000042536.5. [P14270-6]
DR   Ensembl; ENSRNOT00000113369.1; ENSRNOP00000093090.1; ENSRNOG00000042536.5. [P14270-8]
DR   GeneID; 24627; -.
DR   KEGG; rno:24627; -.
DR   AGR; RGD:3281; -.
DR   CTD; 5144; -.
DR   RGD; 3281; Pde4d.
DR   VEuPathDB; HostDB:ENSRNOG00000042536; -.
DR   eggNOG; KOG3689; Eukaryota.
DR   GeneTree; ENSGT00940000155674; -.
DR   HOGENOM; CLU_005940_5_3_1; -.
DR   InParanoid; P14270; -.
DR   OMA; FNTDEGG; -.
DR   OrthoDB; 240889at2759; -.
DR   PhylomeDB; P14270; -.
DR   BRENDA; 3.1.4.53; 5301.
DR   Reactome; R-RNO-180024; DARPP-32 events.
DR   Reactome; R-RNO-418555; G alpha (s) signalling events.
DR   SABIO-RK; P14270; -.
DR   UniPathway; UPA00762; UER00747.
DR   PRO; PR:P14270; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000042536; Expressed in quadriceps femoris and 18 other cell types or tissues.
DR   ExpressionAtlas; P14270; baseline and differential.
DR   GO; GO:0034704; C:calcium channel complex; ISO:RGD.
DR   GO; GO:0005813; C:centrosome; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0030016; C:myofibril; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IBA:GO_Central.
DR   GO; GO:0034705; C:potassium channel complex; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0005891; C:voltage-gated calcium channel complex; ISO:RGD.
DR   GO; GO:0004115; F:3',5'-cyclic-AMP phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0047555; F:3',5'-cyclic-GMP phosphodiesterase activity; IBA:GO_Central.
DR   GO; GO:0004114; F:3',5'-cyclic-nucleotide phosphodiesterase activity; ISO:RGD.
DR   GO; GO:0051117; F:ATPase binding; ISO:RGD.
DR   GO; GO:0031698; F:beta-2 adrenergic receptor binding; IPI:BHF-UCL.
DR   GO; GO:0005246; F:calcium channel regulator activity; ISO:RGD.
DR   GO; GO:0030552; F:cAMP binding; ISO:RGD.
DR   GO; GO:0004112; F:cyclic-nucleotide phosphodiesterase activity; IDA:RGD.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:1901363; F:heterocyclic compound binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0030545; F:signaling receptor regulator activity; IMP:BHF-UCL.
DR   GO; GO:0044325; F:transmembrane transporter binding; ISO:RGD.
DR   GO; GO:0071875; P:adrenergic receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0006198; P:cAMP catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019933; P:cAMP-mediated signaling; ISO:RGD.
DR   GO; GO:0071320; P:cellular response to cAMP; ISO:RGD.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; ISO:RGD.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; ISO:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0061028; P:establishment of endothelial barrier; IDA:UniProtKB.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0007613; P:memory; IMP:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0106072; P:negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0045822; P:negative regulation of heart contraction; ISO:RGD.
DR   GO; GO:0033137; P:negative regulation of peptidyl-serine phosphorylation; ISO:RGD.
DR   GO; GO:1901898; P:negative regulation of relaxation of cardiac muscle; ISO:RGD.
DR   GO; GO:0030593; P:neutrophil chemotaxis; ISO:RGD.
DR   GO; GO:1990266; P:neutrophil migration; ISO:RGD.
DR   GO; GO:0001542; P:ovulation from ovarian follicle; ISO:RGD.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; IMP:RGD.
DR   GO; GO:0010460; P:positive regulation of heart rate; IMP:BHF-UCL.
DR   GO; GO:0032743; P:positive regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:0032754; P:positive regulation of interleukin-5 production; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISO:RGD.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:RGD.
DR   GO; GO:1902514; P:regulation of calcium ion transmembrane transport via high voltage-gated calcium channel; ISO:RGD.
DR   GO; GO:0043949; P:regulation of cAMP-mediated signaling; IMP:RGD.
DR   GO; GO:0086004; P:regulation of cardiac muscle cell contraction; IMP:BHF-UCL.
DR   GO; GO:1901844; P:regulation of cell communication by electrical coupling involved in cardiac conduction; ISO:RGD.
DR   GO; GO:0002027; P:regulation of heart rate; ISO:RGD.
DR   GO; GO:0010880; P:regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum; ISO:RGD.
DR   GO; GO:0006939; P:smooth muscle contraction; ISO:RGD.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; ISO:RGD.
DR   Gene3D; 1.10.1300.10; 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain; 1.
DR   InterPro; IPR040844; PDE4_UCR.
DR   InterPro; IPR023088; PDEase.
DR   InterPro; IPR002073; PDEase_catalytic_dom.
DR   InterPro; IPR036971; PDEase_catalytic_dom_sf.
DR   InterPro; IPR023174; PDEase_CS.
DR   PANTHER; PTHR11347:SF91; CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D; 1.
DR   PANTHER; PTHR11347; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 1.
DR   Pfam; PF18100; PDE4_UCR; 1.
DR   Pfam; PF00233; PDEase_I; 1.
DR   PRINTS; PR00387; PDIESTERASE1.
DR   SUPFAM; SSF101447; Formin homology 2 domain (FH2 domain); 1.
DR   SUPFAM; SSF109604; HD-domain/PDEase-like; 1.
DR   PROSITE; PS00126; PDEASE_I_1; 1.
DR   PROSITE; PS51845; PDEASE_I_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; cAMP; Cell membrane; Cytoplasm; Cytoskeleton;
KW   Hydrolase; Isopeptide bond; Magnesium; Manganese; Membrane; Metal-binding;
KW   Phosphoprotein; Reference proteome; Ubl conjugation; Zinc.
FT   CHAIN           1..803
FT                   /note="3',5'-cyclic-AMP phosphodiesterase 4D"
FT                   /id="PRO_0000198816"
FT   DOMAIN          381..710
FT                   /note="PDEase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01192"
FT   REGION          1..103
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          338..358
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          705..724
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          732..803
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        53..87
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        340..357
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        753..772
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        773..787
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        457
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:Q07343"
FT   BINDING         457
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         457
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         461
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         497
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         498
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         498
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         498
FT                   /ligand="Mn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29035"
FT                   /evidence="ECO:0000250|UniProtKB:Q07343"
FT   BINDING         498
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         498
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         615
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         615
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         618
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         666
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         666
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         669
FT                   /ligand="3',5'-cyclic AMP"
FT                   /ligand_id="ChEBI:CHEBI:58165"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   BINDING         669
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         294
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   MOD_RES         296
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   MOD_RES         370
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08499"
FT   CROSSLNK        382
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..297
FT                   /note="Missing (in isoform 32)"
FT                   /evidence="ECO:0000303|PubMed:8034568"
FT                   /id="VSP_004582"
FT   VAR_SEQ         1..286
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:12834813"
FT                   /id="VSP_012404"
FT   VAR_SEQ         1..264
FT                   /note="MEAEGSSVPARAGSHEGSDSSGGAALKAPKHLWRHEQHHQYPLRQPQFRLLH
FT                   PHHHLPPPPPPSPQPQLQPPPPPPLPPPPPPPGATRGRYASSGASRVRHRGYSDTERYL
FT                   YCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSG
FT                   LILQANFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLR
FT                   TVRNNFAALTNLQDRAPSKRSPMCNQPSINKATIT -> MKEQPSCAGTGHPSMAGYGR
FT                   MAPFELAGGPVKRLRTESPFPCLFA (in isoform 31)"
FT                   /evidence="ECO:0000303|PubMed:2554303,
FT                   ECO:0000303|PubMed:7958996, ECO:0000303|PubMed:8034568"
FT                   /id="VSP_004581"
FT   VAR_SEQ         1..147
FT                   /note="MEAEGSSVPARAGSHEGSDSSGGAALKAPKHLWRHEQHHQYPLRQPQFRLLH
FT                   PHHHLPPPPPPSPQPQLQPPPPPPLPPPPPPPGATRGRYASSGASRVRHRGYSDTERYL
FT                   YCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRR -> MAQQTTSPDTLTVPEVDNP
FT                   HVPNPWLNEDLVKSLRENLLQHEKSKTARKSVSPKLSPVISPRNSPRLLRRMLLSSNIP
FT                   KQRRFTVAHTC (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:17261351"
FT                   /id="VSP_053485"
FT   VAR_SEQ         1..147
FT                   /note="MEAEGSSVPARAGSHEGSDSSGGAALKAPKHLWRHEQHHQYPLRQPQFRLLH
FT                   PHHHLPPPPPPSPQPQLQPPPPPPLPPPPPPPGATRGRYASSGASRVRHRGYSDTERYL
FT                   YCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRR -> MAFVWDPLGVTVPGPSPRT
FT                   RTRLRFSKSYS (in isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:17261351"
FT                   /id="VSP_053486"
FT   VAR_SEQ         1..131
FT                   /note="Missing (in isoform 33)"
FT                   /evidence="ECO:0000303|PubMed:7958996,
FT                   ECO:0000303|PubMed:8034568"
FT                   /id="VSP_012398"
FT   VAR_SEQ         1..125
FT                   /note="Missing (in isoform 9)"
FT                   /evidence="ECO:0000303|Ref.9"
FT                   /id="VSP_012402"
FT   VAR_SEQ         1..56
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:12834813"
FT                   /id="VSP_012400"
FT   VAR_SEQ         57..147
FT                   /note="LPPPPPPSPQPQLQPPPPPPLPPPPPPPGATRGRYASSGASRVRHRGYSDTE
FT                   RYLYCRAMDRTSYAVETGHRPGLKKSRMSWPSSFQGLRR -> MERNTCDVLSRSKSAS
FT                   EETLHSCNDEEDPFRGMEPYLVRRLSSRSIQLPPLAFRQLEQTDLRSESENIPRPTSLP
FT                   LKILPLIAVTSADSTG (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:12834813"
FT                   /id="VSP_012401"
FT   VAR_SEQ         126..147
FT                   /note="GHRPGLKKSRMSWPSSFQGLRR -> MSIIMKPRSRSTSSLRTTEAVC (in
FT                   isoform 9)"
FT                   /evidence="ECO:0000303|Ref.9"
FT                   /id="VSP_012403"
FT   VAR_SEQ         132..147
FT                   /note="KKSRMSWPSSFQGLRR -> MMHVNTFPFRRHSWIC (in isoform
FT                   33)"
FT                   /evidence="ECO:0000303|PubMed:7958996,
FT                   ECO:0000303|PubMed:8034568"
FT                   /id="VSP_012399"
FT   VAR_SEQ         287..301
FT                   /note="ETLQTRHSVSEMASN -> MPEANYLLSVSWGYI (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:12834813"
FT                   /id="VSP_012405"
FT   CONFLICT        226
FT                   /note="A -> N (in Ref. 12; AAA56857)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        357
FT                   /note="S -> P (in Ref. 9; AAQ90405)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        480..486
FT                   /note="Missing (in Ref. 4; AAA18924/AAA18925)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        641
FT                   /note="G -> E (in Ref. 12; AAC26969)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        757
FT                   /note="C -> Y (in Ref. 12; AAA56857)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P14270-8:52
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         P14270-8:56
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
SQ   SEQUENCE   803 AA;  90552 MW;  13E28B257556496D CRC64;
     MEAEGSSVPA RAGSHEGSDS SGGAALKAPK HLWRHEQHHQ YPLRQPQFRL LHPHHHLPPP
     PPPSPQPQLQ PPPPPPLPPP PPPPGATRGR YASSGASRVR HRGYSDTERY LYCRAMDRTS
     YAVETGHRPG LKKSRMSWPS SFQGLRRFDV DNGTSAGRSP LDPMTSPGSG LILQANFVHS
     QRRESFLYRS DSDYDLSPKS MSRNSSIASD IHGDDLIVTP FAQVLASLRT VRNNFAALTN
     LQDRAPSKRS PMCNQPSINK ATITEEAYQK LASETLEELD WCLDQLETLQ TRHSVSEMAS
     NKFKRMLNRE LTHLSEMSRS GNQVSEYISN TFLDKQHEVE IPSPTQKEKE KKKRPMSQIS
     GVKKLMHSSS LTNSCIPRFG VKTEQEDVLA KELEDVNKWG LHVFRIAELS GNRPLTVIMH
     TIFQERDLLK TFKIPVDTLI TYLMTLEDHY HADVAYHNNI HAADVVQSTH VLLSTPALEA
     VFTDLEILAA IFASAIHDVD HPGVSNQFLI NTNSELALMY NDSSVLENHH LAVGFKLLQE
     ENCDIFQNLT KKQRQSLRKM AIDIVLATDM SKHMNLLADL KTMVETKKVT SSGVLLLDNY
     SDRIQVLQNM VHCADLSNPT KPLQLYRQWT DRIMEEFFRQ GDRERERGME ISPMCDKHNA
     SVEKSQVGFI DYIVHPLWET WADLVHPDAQ DILDTLEDNR EWYQSTIPQS PSPAPDDQED
     GRQGQTEKFQ FELTLEEDGE SDTEKDSGSQ VEEDTSCSDS KTLCTQDSES TEIPLDEQVE
     EEAVAEEESQ PQTGVADDCC PDT
//
